T hrombocytopenia is a major concern in intensive care medicine. Its prevalence varies between 13% and 58%, depending on the clinical setting and definition (1) (2) (3) (4) (5) (6) . The highest rates have been seen in septic and trauma patients (4, 6) . Other risk factors associated with thrombocytopenia have been found, including bleeding, transfusions, certain drugs, intravascular catheters, shock, acute respiratory distress syndrome (ARDS), or disseminated intravascular coagulation (DIC) (1, 2, 4, 5, 7) . Hemorrhagic diathesis as a consequence of thrombocytopenia may put intensive care unit (ICU) patients at additional risk of bleeding and may necessitate transfusions. Most studies performed during the last decade have focused on risk factors for thrombocytopenia and included trauma, surgical, or mixed medical/surgical patients or were retrospective in design. We therefore conducted a prospective study to determine prevalence, severity, prognosis, and therapeutic implications of thrombocytopenia in a medical ICU.
PATIENTS AND METHODS
All patients spending Ͼ48 hrs in a 12-bed medical (noncoronary) ICU at the Department of Medicine I at the University of ErlangenNuremberg during a period of 13 months (November 1, 1997, through November 30, 1998) were included. The patients were followed prospectively until they left the ICU or died. Patients with admission platelet counts below 150/nL were excluded from the analysis. Data collected were age, sex, co-morbidity, admission category, ICU diagnosis, and drugs used before admission (2 wks). Daily recording included the Acute Physiology and Chronic Health Evaluation (APACHE) II Score (8) , the Sequential Organ Failure Assessment (SOFA) score (the SOFA score for central nervous system was taken to be zero for all patients) (9) , the presence of intravascular catheters, transfusion requirements, drugs, therapeutic interventions such as surgery, endoscopy, renal replacement therapy, mechanical ventilation, development/presence of bleeding, shock, and DIC. Laboratory data obtained included full blood counts (usually daily), C-reactive protein, serum bilirubin, serum creatinine, serum aspartate aminotransferase, and coagulation tests. The study was approved by the local ethics committee. Informed consent was not required because the study was strictly obser-vational, and all diagnostic tests or therapeutic procedures were done as clinically indicated.
Definitions. Thrombocytopenia was defined as a platelet count of Ͻ150.0/nL (based on the hospital laboratory's reference range). Platelet counts of Ͻ150.0/nL were checked within 24 hrs. The severity of thrombocytopenia was classified as mild, moderate, severe, or very severe on the basis of a nadir platelet count below 150.0/nL, 100.0/nL, 50.0/nL, or 20.0/nL, respectively. Correction of thrombocytopenia was considered to have occurred if platelet counts normalized. Shock was defined as a need for vasoactive drugs for at least 1 hr (Ͼ5 g·kg Ϫ1 ·min Ϫ1 dopamine/dobutamine, Ͼ0.5 g·kg Ϫ1 ·min Ϫ1 dopexamine, epinephrine or norepinephrine at any dose). Septic shock was diagnosed in patients with shock and documented or assumed infection. DIC was considered to be present when D-dimers were elevated in addition to a Ն25% decrease in two of the following markers: prothrombin time (Quick's method in percentage), antithrombin, fibrinogen level, and platelet count within 24 hrs. Only major bleeding episodes were recorded (e.g., drop in hemoglobin of Ն2 g/dL, macrohematuria of Ͼ1 hr, episodes requiring local tamponade or transfusions within 24 hrs, every intracranial hemorrhage). Multiple bleeding events at the same location (e.g., gastrointestinal) were counted only once for each patient.
Statistical Analysis. Groups of patients were compared using the Mann-Whitney U test (continuous variables) and Fisher's exact test (categorical variables). Logistic regression analysis was used to determine the odds ratios (ORs) and corresponding 95% confidence intervals (CIs) of selected factors significantly associated with thrombocytopenia, ICU death, and bleeding in univariate analysis. Owing to skewed distributions, data are presented as medians with 25% to 75% percentiles in parenthesis, unless otherwise noted. The area under the receiver operating characteristic curve was used to assess the discriminative power of the APACHE II score, the SOFA score, and the drop in platelet count in relation to ICU death. Data were analyzed by using SPSS for Windows release 9.0.1 (SPSS, Chicago, IL).
RESULTS

Patients.
A total of 243 of 610 patients remained in the ICU for Ͼ48 hrs. A total of 98 patients with thrombocytopenia at admission were excluded. We studied 145 patients (57% male patients) with a mean age of 60.3 yrs (SD, Ϯ16.9 yrs; range, 18 -96 yrs). Major reasons for ICU admission included respiratory failure (69 cases), monitoring (30 cases), cardiopulmonary resuscitation (17 cases), circulatory failure (10 cases), stupor or coma (9 cases), hepatic failure (6 cases), renal failure (3 cases), and seizure (1 case). The patients had a median first-day APACHE II score of 22 (25% to 75% percentile, [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] , and a median SOFA score of 4 (2-7 (Fig. 1) .
Factors revealed on univariate analysis to be significantly associated with bleeding are shown in Table 2 . In a logistic regression analysis of these factors, only nadir platelet count remained significantly associated with a higher risk of bleeding (p ϭ .0004; OR, 4.1 for every 100.0/nL; 95% CI, 1.9 -8.8) and respiratory failure as admission category with a lower risk of bleeding (p ϭ .0157; OR, 0.3; 95% CI, 0.1-0.8) in comparison with other admission categories.
Transfusion Requirements. Transfusion requirements are summarized in Table 3. The 8% of patients with nadir platelet counts of Ͻ50.0/nL consumed 36% of the total number of units of fresh frozen plasma used, 38% of antithrombin, 39% of packed red blood cells, and 97% of single donor apheresis platelets. Most of the blood products were given after thrombocytopenia had occurred (78% of packed red blood cells, 80% of antithrombin, 82% of fresh frozen plasma, 100% of single donor apheresis platelets).
Outcome In the overall cohort, DIC, septic shock, APACHE II score, SOFA score, nadir platelet count (all p Ͻ .001), duration of thrombocytopenia (p ϭ .008), C-reactive protein (p ϭ .013), thrombocytopenia (p ϭ .03), and ARDS at admission (p ϭ .032) were shown by univariate analysis to be significantly associated with ICU mortality. Multiple logistic regression analysis showed that septic shock (p ϭ .008; OR, 3.65; 95% CI, 1.40 -9.52), a higher APACHE II score (p ϭ .048; OR, 1.06 for 1 point; 95% CI, 1.01-1.12), and a 30% or higher decrease in platelet counts (p ϭ .019; OR, 3.73; 95% CI, 1.24 -11.21) were significant risk factors for ICU death. ICU-acquired thrombocytopenia was not independently associated with mortality in this analysis (p ϭ .17). The (Fig. 2) . In thrombocytopenic patients, mortality was not associated with age, sex, admission category, preexisting chronic disease, SOFA at admission, hemoglobin, renal replacement therapy, episodes of bleeding, or bacteremia. 
DISCUSSION
Platelet counts dropped in most of the patients during the ICU stay, and thrombocytopenia (Ͻ150.0/nL) emerged in 44% of them. This prevalence of ICUacquired thrombocytopenia was much higher than recently reported in a predominantly medical population (47 of 240 patients, 20%) (10). The difference may reflect different inclusion criteria. We excluded patients with an ICU stay of Ͻ48 hrs, which may have selected more severely sick patients, as documented by a higher APACHE II score in our cohort (median 22 vs. 18) (10). In earlier reports, the prevalence of thrombocytopenia ranged between 13% and 58% (1-6). Higher figures were found in trauma and septic patients (4, 6) . These variations may be explained in part by different thresholds in defining thrombocytopenia (platelet count of Ͻ100.0, Ͻ150.0, Ͻ200.0/nL). Taking into account only patients with nadir platelet counts of Ͻ100.0/nL, a prevalence rate of 21% is within the range of two previous retrospective studies in medical patients (1, 11) . As reported in trauma patients (4), platelet counts also dropped in patients with a nadir platelet count Ն 150.0/nL. This mild decrease may have various causes (e.g., inflammation, fluid resuscitation, or heparin). Heparin prophylaxis was given to most of our patients (87%). Heparin is known to cause an early temporary drop in platelet counts in 10% to 30% of patients (12, 13) (heparin-induced thrombocytopenia type I), which does not always reach nadir platelet counts of Ͻ150.0/nL.
The development of DIC was the leading risk factor for ICU-acquired thrombocytopenia. Intravascular destruction of platelets that accompanies the activation and consumption of coagulation factors is the most common cause of thrombocytopenia in critically ill patients (7) . Most of the patients with DIC had septic shock (82%), confirming systemic infection as the most important cause of DIC (14, 15) . As previously reported, patients with sepsis/septic shock showed a higher prevalence of thrombocytopenia (1, 6, 10, 16), but this association was no longer significant in our cohort after correction for DIC using logistic regression analysis. This may be because of the fact that we analyzed patients with septic shock and not with sepsis. In septic shock, the prevalence of DIC (51% in our patients) is higher than in sepsis or severe sepsis (17) . In addition, most previous studies did not evaluate DIC as a risk factor for thrombocytopenia (1, 2, 4, 11) . Shock, on the other hand, is a known determinant of thrombocytopenia (11) . Cardiopulmonary resuscitation was not defined as a risk factor for thrombocytopenia in earlier reports. Three patients requiring cardiopulmonary resuscitation received thrombolytic therapy (for suspected pulmonary embolism or myocardial infarction), but only two developed thrombocytopenia. In one patient, aggressive initial fluid resuscitation may have contributed to the development of thrombocytopenia.
No obvious cause was detectable in the other ten patients undergoing cardiopulmonary resuscitation. A higher admission SOFA score identifying more severely ill patients was also independently predictive for ICU-acquired thrombocytopenia, as previous studies have also shown for a higher APACHE II score (5) or elevated serum bilirubin and creatinine (1) . As reported in a surgical ICU population (5), patients with higher baseline platelet counts had a slightly reduced risk of thrombocytopenia. But the CI for the OR (CI, 0.41-0.99) is wide and close to 1 in logistic regression analysis, making this prediction unreliable.
Liver disease or hematologic disorders are frequent causes of thrombocytopenia that have been described in critically ill patients as well (10) . Excluding all patients with thrombocytopenia at admission, we were unable to find any difference in preexisting diseases between those who developed thrombocytopenia and those who did not. Invasive vascular access, such as pulmonary artery catheters (9, 18) and arterial or central venous catheters (2) , is linked to the occurrence of thrombocytopenia in the literature but may simply reflect severity of illness and local treatment practice. Thus, in a recent report (2) , arterial or central catheters were used in 58% of patients compared with 88% in our cohort.
Many drugs commonly used in the ICU can cause thrombocytopenia, and most ICU patients are receiving a large number of different drugs (7). Nevertheless, drug-induced thrombocytopenia seems to be of minor importance in these patients (1, 2, 4) . Catecholamines, quinolones, and nonsteroidal anti-inflammatory drugs were associated with platelet counts of Ͻ150.0/nL on univariate analysis, probably as indicators for a group of more severely ill patients. The low prevalence of drug-induced thrombocytopenia and the high frequency of confounding factors such as sepsis, DIC, or bleeding makes the diagnosis of druginduced thrombocytopenia difficult in the ICU setting. Hence, a low threshold of suspicion is needed to prevent the underdiagnosis of drug-induced thrombocytopenia, particularly in patients receiving heparin, because heparin-induced thrombocytopenia type II is relatively common and may cause serious complications (13, 19) . Two of our patients (1%) developed heparin-induced thrombocytopenia type II, which was confirmed by laboratory testing, and were successfully treated with danaparoid.
In surgical or trauma ICU patients, bleeding and transfusions contribute significantly to the development of thrombocytopenia (4, 5, 20) . However, in our medical population, episodes of bleeding and transfusions were much more common after the occurrence of thrombocytopenia rather than before. Bleeding and transfusions were therefore not a major cause but a frequent complication of thrombocytopenia. The patient's risk of bleeding increased with the severity of thrombocytopenia (Fig. 1) .
Compared with patients without thrombocytopenia, the risk of bleeding was more than three times as high in those with platelet counts of Ͻ150.0/nL and six times as high in those with platelet counts of Ͻ50.0/nL. In contrast to a recent report (10) , no plateau was seen below a platelet count of 100.0/nL. Even patients with mild thrombocytopenia had a significantly higher disposition for bleeding than those without (p ϭ .009). On univariate analysis, the presence and duration of thrombocytopenia and basal and nadir platelet count were seen to be significantly related to bleeding, confirming the importance of platelet counts as a risk-marker in these patients. Moreover, nadir platelet count was the only identifiable independent risk factor for bleeding on logistic regression analysis. Reflecting the bleeding rate, transfusion require- ments were higher in thrombocytopenic patients. Within this cohort, the need for transfusions increased with the severity of thrombocytopenia (Fig. 1) . Nearly all single donor apheresis platelets and more than one third of other blood products were consumed by the 8% of patients with a nadir platelet count of Ͻ50.0/nL. Blood products are an important part of the high levels of care these patients require, as is reflected by their longer ICU stay, greater need of mechanical ventilation, and renal replacement therapy.
As previously reported (1, 2, 5, 6, 10, 21), ICU mortality is significantly higher in thrombocytopenic patients (31% vs. 16%). Mild thrombocytopenia did not influence mortality, but below the platelet threshold of 100.0/nL, mortality increased with the severity of thrombocytopenia, exceeding 50% in patients with nadir platelet counts of Ͻ50.0/nL. After correction for other contributing factors such as the APACHE II score or the presence of septic shock, a decrease in the platelet count of Ͼ30%, but not the occurrence of thrombocytopenia itself, was predictive of mortality. Furthermore, even a blunted rise in platelet count seems to be associated with a poor outcome (22) . To some degree, therefore, the platelet count may characterize the patient's overall condition and disease progression, but changes over time rather than absolute counts may be predictive of an adverse outcome. In contrast, Vanderschueren et al. (10) recently found thrombocytopenia to be a predictor of ICU mortality, independent of disease severity at admission. But the presence of septic shock in particular was not analyzed, and patients with thrombocytopenia at admission were not excluded, so their results are not directly comparable with ours. Because platelet counts are easy to measure and are repeatedly assessed in ICU patients, they may help to monitor patient status in the ICU, especially in units not using severity scoring systems. In our cohort, declining platelet counts predicted mortality as reliably as did SOFA or APACHE II scores. Using platelet counts to monitor patients makes sense only when thrombocytopenia is not a late or preterminal complication. In most patients, thrombocytopenia occurred early during their ICU stay, and only a quarter of nonsurvivors died within the first 3 days of thrombocytopenia. As reported for surgical patients (5), correction of thrombocytopenia was independently associated with survival in our patients. Moreover, the decline in platelet counts was twice as high in nonsurvivors than in survivors, which further underscores the potential of platelet counts for monitoring patient status over time.
In the thrombocytopenic cohort, in addition to septic shock, a higher white blood cell count reflecting a greater degree of inflammation and the presence of ARDS on the first day of thrombocytopenia were independently related to death. Thrombocytopenia is a well-known condition in ARDS (23) (24) (25) . Patients with ARDS developing thrombocytopenia have a higher mortality rate than those who do not (26) . Our results seem to show that this is also true in patients with thrombocytopenia developing ARDS. Wide CIs indicate that these risk factors should be interpreted with caution on account of the limited number of patients in this subgroup.
Our study has a number of shortcomings. In critically ill patients, various confounding factors are present at different times. It is not possible to control for them all. Treatment strategies may have a major impact on disease progression and even on definitions (e.g., single donor apheresis platelet transfusions on platelet counts or higher positive endexpiratory pressure in ARDS). To minimize the effect of such problems, we did not change our major treatment regimens during the study period. Because of the limited number of patients, the impacts of rare events or factors (e.g., druginduced thrombocytopenia) could not be adequately analyzed. Despite the use of common definitions and few exclusion criteria, our results cannot simply be transferred to other ICUs because case mix and treatment protocols vary greatly from one ICU to another.
CONCLUSIONS
Platelet counts of Ͻ150.0/nL are common in medical ICU patients. Thrombocytopenic patients have a higher prevalence of bleeding, greater transfusion requirements, a longer ICU stay, and higher mortality. Sequential measurements of platelet counts are readily available markers of disease progression. A drop in platelet count is an unfavorable prognostic sign and needs urgent clarification. In medical ICU patients, newly acquired thrombocytopenia is mostly associated with septic shock, bacteremia, or DIC. Independent predictors of thrombocytopenia are cardiopulmonary resuscitation before admission, DIC, and a higher SOFA score. Drug-induced thrombocytopenia may be important in the individual patient, but is not a major problem in the overall cohort.
